| 1 |
34940773 | Multi-ligand modified PC@DOX-PA/EGCG micelles effectively inhibit the growth of ER+, PR+ or HER2+ breast cancer. | 2022 Jan 19 |
1 |
| 2 |
31934166 | ERĪ±36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma. | 2019 |
2 |
| 3 |
29329808 | Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2. | 2018 May |
1 |
| 4 |
30207689 | Cascaded Aptamers-Governed Multistage Drug-Delivery System Based on Biodegradable Envelope-Type Nanovehicle for Targeted Therapy of HER2-Overexpressing Breast Cancer. | 2018 Oct 10 |
4 |
| 5 |
28462491 | In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells. | 2017 Aug |
1 |
| 6 |
26107737 | Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs. | 2015 |
1 |
| 7 |
20664987 | In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells. | 2010 Sep |
1 |
| 8 |
19113837 | (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. | 2009 Jan 20 |
1 |
| 9 |
19420761 | Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. | 2009 May |
2 |
| 10 |
19438225 | (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2. | 2009 Jul-Aug |
1 |
| 11 |
17902053 | Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75. | 2008 Jun |
1 |
| 12 |
18618485 | Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. | 2008 Jul |
4 |
| 13 |
19189648 | Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals. | 2008 Nov-Dec |
2 |
| 14 |
19325845 | Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. | 2008 Jun |
4 |
| 15 |
17539658 | Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. | 2007 Jun 27 |
1 |
| 16 |
17575143 | Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. | 2007 Jun 15 |
2 |
| 17 |
17909003 | Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. | 2007 Oct 1 |
5 |
| 18 |
16707458 | Microarray-assisted pathway analysis identifies mitogen-activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells. | 2006 May 15 |
1 |
| 19 |
15814656 | (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. | 2005 Apr 1 |
7 |
| 20 |
16053920 | EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. | 2005 Sep 2 |
1 |
| 21 |
16140980 | Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. | 2005 Sep 1 |
1 |
| 22 |
16416603 | EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. | 2005 |
3 |
| 23 |
12960141 | Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. | 2003 Aug 15 |
1 |
| 24 |
11830514 | Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. | 2002 Feb 1 |
7 |